News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Pacific Biosciences Strikes $75 Million Deal With Roche Diagnostics Corporation (ROG.VX)


9/25/2013 8:48:57 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Pacific Biosciences of California Inc. will get $35 million upfront and possibly $40 million more in a deal to make diagnostic products with Roche Diagnostics. Menlo Park-based Pacific Biosciences (NASDAQ: PACB) will develop sequencing systems and consumable products under the deal, and will sell them exclusively to Roche, which has paid for an exclusive license to use the products for nucleic acid sequencing in human in vitro diagnostics. Pacific Biosciences will keep selling its products in other fields.

Help employers find you! Check out all the jobs and post your resume.

Read at San Francisco Business Times
Read at RTT News
Read at Nasdaq

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES